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My aspirations for the IMS 
 
Mary Ann Lumsden 
President of the International Menopause Society, School of Medicine, University of 
Glasgow, Glasgow Royal Infirmary, Glasgow, UK 
 
I am a Professor of Medical Education and Gynaecology at the University of Glasgow and Honorary 
Consultant Gynaecologist at Glasgow’s Royal Infirmary, posts that I have held for 23 years. I am very 
honored to have been elected as the 13th President of the International Menopause Society (IMS). I 
am the first female President but I follow on from a line of very distinguished male Presidents. My 
predecessor, Rod Baber, has achieved all his aspirations during his time as President and I hope that 
I will be equally effective. It has been a very happy 2.5 years under his leadership which started with 
the very successful congress in Cancun and ended with the arguably even more successful meeting 
in Prague. 
 
For what am I aiming over the next 2 years? I feel that one of the most important things is to join 
with others working in the same area rather than competing with them. Together with other 
national societies around the world, I feel that we can achieve more than if we are all acting 
separately. In 2017, I will be visiting Colombia, Singapore, India and China on behalf of the IMS, to 
share the knowledge and expertise that I have acquired here in the UK and previous excursions 
overseas. I am lucky to work for the University of Glasgow, since Glasgow is a very vibrant city in 
Scotland, where I see women and their partners from all backgrounds but who need help to deal 
with the issues that threaten to diminish the quality of their lives. 
 
I have worked with and learnt from many throughout the world. However, not all health 
professionals have the opportunity of having specialized advice but still need to be able to help the 
women in midlife who are seen by them in their clinics. My aim is to help more health-care 
professionals and doctors in more specialties and in more countries to take seriously the problems 
with which our patients present and to help them to find a solution. To this end, I will be 
encouraging the educational arm of the IMS to develop even further since education is one of the 
main aims of the IMS. This may be at the biennial World Congress and the Regional Meetings or in 
the very valuable information we produce, from leaflets to YouTube videos. Our educational 
initiatives are headed up by Dr Duru Shah from Mumbai and Professor Amos Pines from Tel Aviv. 
Duru has set up several new initiatives, including webinars, and several of these have taken place 
over the last year. She has also been responsible for obtaining a grant to develop an accreditation 
system for menopause experts around the world and you will hear more about this very exciting 
initiative as the year progresses. 
 
The care of women in midlife is the reason why this society is in existence. This does not just include 
issues related to declining hormone levels but also the impact of aging and chronic disease on 
women who may spend one-third of their lives in the postmenopause. All women become 
menopausal unless they die during the reproductive years. Many women will be leading full and 
active lives and so need to be able to fulfil all their aspirations. It is for this reason that we concern 
ourselves with all aspects of healthy aging and prevention of disease. This is also the aim of other 
national colleges of Obstetrics and Gynecology and the specialist societies in women’s health. I have 
the privilege of also being the Senior Vice President of the Royal College of Obstetricians and 
Gynaecologists in London, another organization that has the care of women in midlife within its 
larger remit. Older women are often forgotten in the struggle to lower pregnancy-related mortality 
and morbidity. We must keep reminding policymakers, funders and the public in general of the 
importance of older women and the potential opportunity to involve them in health education and 
screening. I feel that the opportunity should not be missed of using all that these organizations have 
to offer to work to a common end. 
 
The managerial aspects of the IMS are watched over very carefully by Lee Tomkins, our CEO, and her 
assistant Martin Derbyshire. Both are very dedicated to the IMS and its security and both are always 
readily available to help with problems and queries as well as to share the successes. Lee has also 
helped Victor Henderson, our previous General Secretary, from the US, who took on the very 
important task of reviewing many aspects of the Society’s governance, to make sure we work in the 
way that befits our charity status. He has now been succeeded by Tommaso Simoncini from Pisa 
who, I am sure, will contribute to this post and the Society as a whole. 
 
Rod Baber’s aim was to work towards financial stability and I think this has been achieved. We have 
moved our account from one bank to another more suited to our requirements and are currently 
able to achieve a better return at lower cost. This, of course, may change over the next few months 
but, in the longer term, we anticipate that our reserves will be safe. Our finances will be helped by 
the fact that the Prague Congress was a tremendous success. It was a high-quality meeting with a 
good attendance, excellent presentations and good networking. The Scientific Program Committee 
was chaired by Professor Susan Davis, a senior academic from Melbourne in Australia, whose 
support as President-Elect I look forward to enjoying in the next 18 months. 
 
We have already started to plan for the Vancouver Congress in 2018 with invitations going out 
already to a number of plenary speakers. Dr Nick Panay, Chelsea and Westminster Hospital, London, 
will be at the helm of the Scientific Committee planning the program, which will be different and 
exciting. This meeting will focus more on younger menopausal women including those with 
premature ovarian insufficiency and in the perimenopause. We will talk about the common issues 
affecting women at this stage of life, with plenty of practical advice to guide clinicians’ practice in the 
future. All of us on the Board of Trustees hope that we will see you in Vancouver. It is a truly 
beautiful city and the program promises to be excellent. We will emphasize the contributions of 
young researchers working in the field, with development of projects to make sure all are aware of 
the excellent research many of them undertake. They are the IMS of the future and we need to 
value them. 
 
Visiting those involved in the care of women in midlife is an important aspect of our work. Over the 
next year, accompanied by other Board members, I will be visiting Columbia, Singapore, India and 
China on behalf of the IMS. We will be holding our next Regional meeting in Belgrade, Serbia in 2017 
and this promises to be an exciting meeting. The Regional meeting in Taiwan in 2015 was very 
successful and introduced many of the Board members attending to a new and attentive audience. 
As an international society, it is most important that we do reach out to those less familiar with 
menopausal medicine throughout the world. 
 
We are keen that the Society continues to grow and to attract new and committed members. The 
IMS now has a new category of Associate member, aimed at the young and those living in 
developing countries with less accessible wealth. We hope that this will encourage individuals and 
groups to be involved in the Society and that they will then go on to become full members. The 
Membership Working Party was led by Steve Goldstein from New York; he is now our Treasurer and 
will continue to work towards developing initiatives to ensure a steady increase in those interested 
in the IMS. 
 
The Executive Officers and the Board of Trustees are drawn from around the world and include 
representatives of all the major national societies in menopause medicine as well as other national 
organizations. This is a wonderful opportunity to work with others to achieve our aim of improving 
midlife women’s health around the world. 
  
